93616-27-4CC(=O)N[C@H]1[C@H](O[C@@H]2c3ccc(c(O)c3)Oc3cc4cc(c3)[C@@H](NC(=O)[C@H]3NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O4)NC(=O)[C@H](N)c4ccc(O)c(c4)Oc4cc(O)cc3c4)C(=O)N[C@H]3C(=O)N[C@@H]2C(=O)N[C@H](C(=O)O)c2cc(O)cc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c2-c2cc3ccc2O)O[C@H](CO)[C@@H](O)[C@@H]1ODYTVXQIVJILNOQ-PIRWUWTNSA-N93616-27-4VerwendenTeicoplanin A3-1 is a minor polar analogue of a family of lipoglycopeptides produced by Actinoplanes teichomyceticus. Teicoplanins possess potent broad spectrum antibiotic activity against Gram positive bacteria, including MRSA and E. faecalis. Teicoplanin A3-1 is the common degradation product of teicoplanins A2-1 to 5, resulting from cleavage of the lipoaminoglycoside substituents.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
DefinitionChEBI: A glycopeptide consisting of a macropolycyclic heptapeptide in which a phenolic hydroxy group has been converted to its alpha-D-mannoside while a secondary alcohol group has been converted to the corresponding 2-acetamido- -deoxy-beta-D-glucoside.